Vivien W. Chan
Eureka Therapeutics (United States)(US)
Publications by Year
Research Areas
CAR-T cell therapy research, T-cell and B-cell Immunology, Immunotherapy and Immune Responses, Monoclonal and Polyclonal Antibodies Research, Immune Cell Function and Interaction
Most-Cited Works
- → The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity(2012)8,404 cited
- → Macrophage IL-10 Blocks CD8+ T Cell-Dependent Responses to Chemotherapy by Suppressing IL-12 Expression in Intratumoral Dendritic Cells(2014)973 cited
- → Characterization of the B Lymphocyte Populations in Lyn-Deficient Mice and the Role of Lyn in Signal Initiation and Down-Regulation(1997)445 cited
- → Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/β-catenin signaling is activated in human colon tumors(2001)367 cited
- beta-Catenin regulates vascular endothelial growth factor expression in colon cancer.(2003)
- → Targeting Alpha-Fetoprotein (AFP)–MHC Complex with CAR T-Cell Therapy for Liver Cancer(2016)227 cited
- → Proliferative aspects of airway smooth muscle(2004)216 cited
- → Defective negative regulation of antigen receptor signaling in Lyn-deficient B lymphocytes(1998)171 cited
- → Secondary Lymphoid-Tissue Chemokine (SLC) Is Chemotactic for Mature Dendritic Cells(1999)130 cited
- → Membrane Ig cross-linking regulates phosphatidylinositol 3-kinase in B lymphocytes(1992)125 cited